We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-34.3%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$115M
AUM Growth
+$792K
Cap. Flow
+$6.43M
Cap. Flow %
5.6%
Top 10 Hldgs %
83.12%
Holding
142
New
32
Increased
15
Reduced
32
Closed
53

Top Buys

Rank Stock Value
1
RCON icon
Recon Technology
RCON
+$5M
2
GMVD
G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
+$3.87M
3
BETS
Bit Brother Limited Class A Ordinary Shares
BETS
+$2.24M
4
CNEY icon
CN Energy Group
CNEY
+$2.19M
5
NMTR
9 Meters Biopharma
NMTR
+$2.08M

Top Sells

Rank Stock Value
1
NVCT icon
Nuvectis Pharma
NVCT
+$4.41M
2
TBLT
ToughBuilt Industries, Inc. Common Stock
TBLT
+$2.28M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$1.92M
4
BGXX
Bright Green Corporation Common Stock
BGXX
+$1.49M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 9.81%
2 Technology 3.12%
3 Consumer Discretionary 2.1%
4 Communication Services 1.53%
5 Materials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RKDA icon
26
Arcadia Biosciences
RKDA
$1.37M
$395K 0.34%
+52,874
New +$561K
BBLG
27
Bone Biologics
BBLG
$1.74M
$388K 0.34%
1,042
+183
+21% +$76.4K
ADTX
28
DELISTED
ADITXT INC
ADTX
– –
0
– –
VINC
29
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$368K 0.32%
17,670
-7,330
-29% -$164K
INBS icon
30
Intelligent Bio Solutions
INBS
$3.8M
$367K 0.32%
+1,055
New +$968K
WLDSW icon
31
Wearable Devices Ltd Warrant
WLDSW
$135K
$366K 0.32%
3,701
+36
+1% +$3.33K
LFWD icon
32
ReWalk Robotics
LFWD
$19.6M
$362K 0.32%
5,982
-2,322
-28% -$153K
AIOS
33
AIOS Tech
AIOS
$41.1M
$351K 0.31%
3,669
-1,684
-31% -$186K
FUV
34
DELISTED
Arcimoto, Inc. Common Stock
FUV
$350K 0.3%
+250,000
New +$554K
TTOO
35
DELISTED
T2 Biosystems, Inc
TTOO
$345K 0.3%
+7,496
New +$818K
SVRN
36
OceanPal Inc
SVRN
$11.7M
$335K 0.29%
+96
New +$678K
ATXI
37
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$326K 0.28%
3,732
+212
+6% +$19.6K
BBIO icon
38
CALL
BridgeBio Pharma
BBIO
$16.8B
$322K 0.28%
+194
New +$2.26K
GEVO icon
39
Gevo
GEVO
$363M
$293K 0.26%
190,380
-25,889
-12% -$49K
MMAT
40
PUT
DELISTED
Meta Materials Inc. Common Stock
MMAT
$273K 0.24%
67
-19
-22% -$1.48K
ARQQ icon
41
Arqit Quantum
ARQQ
$305M
$250K 0.22%
+7,133
New +$337K
REVB icon
42
Revelation Biosciences
REVB
$4.06M
$235K 0.2%
+31
New +$837K
NEPT
43
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$217K 0.19%
10,041
-17,357
-63% -$416K
MOBQ
44
DELISTED
Mobiquity Technologies, Inc. Common Stock
MOBQ
$201K 0.18%
+74,788
New +$448K
HIND
45
Vyome Holdings
HIND
$14M
$192K 0.17%
+13
New +$422K
PBLA
46
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$189K 0.16%
+711
New +$689K
DVLT
47
Datavault AI
DVLT
$281M
$181K 0.16%
+776
New +$759K
AMPGW
48
DELISTED
Amplitech Group Warrants
AMPGW
$151K 0.13%
381,705
-44,082
-10% -$17.3K
LEXXW
49
DELISTED
Lexaria Bioscience Warrant
LEXXW
$150K 0.13%
263,198
+43,385
+20% +$23.9K
ONFO icon
50
Onfolio Holdings
ONFO
$808K
$144K 0.13%
90,210
-3,290
-4% -$5.83K
1
2
3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2023 Portfolio in Review

As of Q1 2023, Sabby Management held 142 positions worth $115M, up 0.69% from $114M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Sabby Management deployed $6.43M of net new capital in Q1 2023, opening 32 new positions and adding to 15 existing holdings. Its largest new stake was Recon Technology: 219,315 shares worth $1.35M.

By sector, the portfolio is most concentrated in Healthcare at 9.8% of assets, down from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Cocrystal Pharma, an estimated $792K trimmed.

  • Sabby Management's largest Q1 2023 buy was Recon Technology: 219,315 shares worth $1.35M.
  • Sabby Management added most to Akari Therapeutics in Q1 2023, an estimated $1.68M increase.
  • Sabby Management's biggest Q1 2023 reduction was Cocrystal Pharma, cutting an estimated $792K.
  • Sabby Management fully exited Nuvectis Pharma in Q1 2023, selling an estimated $4.41M.
  • Sabby Management's ten largest holdings make up 83% of its $115M portfolio in Q1 2023.
  • Sabby Management opened 32 new positions and closed 53 in Q1 2023.
  • Sabby Management's portfolio value rose 0.69% quarter-over-quarter to $115M.

Based on Sabby Management's 13F filing for Q1 2023, filed 15 May 2023.